Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study - Cappuzzo, F; Ciuleanu, T; Stelmakh, L (Lancet Oncol, 2010)
, et al; SATURN investigators.